Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

FDA gives priority review to Pfizer RSV vaccine for older adults

Por: The Hill Health December 09, 2022

thumbnail

The Food and Drug Administration (FDA) accepted Pfizer’s application for an RSV vaccine for older adults, and is expected to make an approval decision by the spring.  Pfizer in a statement on Wednesday said the FDA is going to review its application under the priority review program, which reduces the approval timeline by four months. The end of the review period is expected to be May 2023, Pfizer said. “With no RSV vaccines currently... + full article



Similar News

FDA expected to decide on Pfizer RSV vaccine for older adults by May 2023

CNBC USA Health December 07, 2022

thumbnailIn this articlePfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys... + más

After promising trial results for maternal RSV vaccine, Pfizer says it will seek FDA approval this year | CNN

Strong RSV vaccine data lifts hopes after years of futility | 10 WBNS


When Will the RSV Vaccine be Available? Pfizer Jab Shows 'Positive' Results

Newsweek USA Health November 02, 2022

thumbnailPfizer announced positive trial results on Tuesday for a vaccine designed to help protect against the respiratory syncytial virus, or RSV, potentially setting up the company to have the first shot of its kind to be approved against the virus.The exact timeline for the vaccine... + más

Strong RSV vaccine data lifts hopes after years of futility | 10 WBNS

Pfizer says study shows vaccinating pregnant women protects newborns from RSV | ABC7


Strong RSV vaccine data lifts hopes after years of futility

WPLG Local 10 USA Health November 01, 2022

thumbnailNew research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals each fall.The preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be... + más

Strong RSV vaccine data lifts hopes after years of futility | 10 WBNS

Strong RSV vaccine data lifts hopes after years of futility | ABC News


Pfizer says study shows vaccinating pregnant women protects newborns from RSV

ABC7 USA Health November 01, 2022

thumbnailNew research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals with wheezing babies each fall.The preliminary results buoy hope that after decades of failure and frustration, vaccines... + más

Strong RSV vaccine data lifts hopes after years of futility | 10 WBNS

Pfizer Says Its Maternal RSV Vaccine Can Protect Newborns From Severe Illness | NBC 6 South Florida


Strong RSV vaccine data lifts hopes after years of futility

ABC News USA Health November 01, 2022

thumbnailNew research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals with wheezing babies each fall.The preliminary results buoy hope that after decades of failure and frustration, against RSV may... + más

Strong RSV vaccine data lifts hopes after years of futility | 10 WBNS

Strong RSV vaccine data lifts hopes after years of futility | WPLG Local 10


After promising trial results for maternal RSV vaccine, Pfizer says it will seek FDA approval this year

CNN USA Health November 01, 2022

thumbnailCNN  —  Pfizer says it has enough promising data on its respiratory syncytial virus, or RSV, vaccine designed to protect newborns that it will end enrollment in the study and submit for US Food and Drug Administration approval by the end of the year. RSV is a common... + más

Pfizer announces promising developments for 1st maternal RSV vaccine | ABC News

When Will the RSV Vaccine be Available? Pfizer Jab Shows 'Positive' Results | Newsweek


Strong RSV vaccine data lifts hopes after years of futility

10 WBNS USA Health November 01, 2022

thumbnailNEW YORK — shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals each fall. The preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be... + más

Strong RSV vaccine data lifts hopes after years of futility | WPLG Local 10

Strong RSV vaccine data lifts hopes after years of futility | ABC News



About iurex | Privacy Policy | Disclaimer |